Lytica Therapeutics
Lytica Therapeutics
  • Home
  • Team
  • News
  • Careers
  • Contact
  • More
    • Home
    • Team
    • News
    • Careers
    • Contact
  • Sign In

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Team
  • News
  • Careers
  • Contact

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

May 2, 2022

Lytica Therapeutics is accepted into the Blue Knight program, a joint initiative by Johnson & Johnson Innovation and BARDA

October 19, 2021

Rida Mourtada, Lytica's Chief Scientific Officer, discusses the importance of push mechanisms in revitalizing the antibiotic pipeline at the Milken Global Conference

October 16, 2020

Loren Walensky, Lytica Scientific Cofounder, recognized by Nature Biotechnology as One of the World's Top 20 Translational Researchers of 2019

February 18, 2020

Lytica Therapeutics Receives CARB-X Award For Up To  $16.9 Million To Develop Antimicrobial Peptides To Treat Drug-Resistant Infections

October 7, 2019

Stapled Antimicrobial Peptide Design, as published in the October Issue of Nature Biotechnology

Copyright © 2019-2022 Lytica Therapeutics, Inc - All Rights Reserved.


Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies.

DeclineAccept & Close